Characterization of Transcriptional Changes in ERG Rearrangement-Positive Prostate Cancer Identifies the Regulation of Metabolic Sensors Such as Neuropeptide Y

• Petra Massoner ,

  Contributed equally to this work with: Petra Massoner, Karl G. Kugler

  * E-mail: Petra.Massoner@i.med.ac.at (PM); Helmut.Klocker@uki.at (HK)

  Affiliations Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria, Oncotyrol, Center for Personalized Cancer Medicine GmbH, Innsbruck, Austria

  ⨯
• Karl G. Kugler ,

  Contributed equally to this work with: Petra Massoner, Karl G. Kugler

  Affiliation Institute for Bioinformatics and Translational Research, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria

  ⨯
• Karin Unterberger,

  Affiliation Oncotyrol, Center for Personalized Cancer Medicine GmbH, Innsbruck, Austria

  ⨯
• Ruprecht Kuner,

  Affiliation Unit Cancer Genome Research, Division of Molecular Genetics, German Cancer Research Center and National Center of Tumor Diseases, Heidelberg, Germany

  ⨯
• Laurin A. J. Mueller,

  Affiliation Institute for Bioinformatics and Translational Research, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria

  ⨯
• Maria Fälth,

  Affiliation Unit Cancer Genome Research, Division of Molecular Genetics, German Cancer Research Center and National Center of Tumor Diseases, Heidelberg, Germany

  ⨯
• Georg Schäfer,

  Affiliation Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria

  ⨯
• Christof Seifarth,

  Affiliation Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria

  ⨯
• Simone Ecker,

  Affiliation Institute for Bioinformatics and Translational Research, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria

  ⨯
• Irmgard Verdorfer,

  Affiliation Division of Human Genetics, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria

  ⨯
• Armin Graber,

  Affiliation Institute for Bioinformatics and Translational Research, University for Health Sciences, Medical Informatics and Technology (UMIT), Hall in Tirol, Austria

  ⨯
• Holger Sültmann,

  Affiliation Unit Cancer Genome Research, Division of Molecular Genetics, German Cancer Research Center and National Center of Tumor Diseases, Heidelberg, Germany

  ⨯
• Helmut Klocker

  * E-mail: Petra.Massoner@i.med.ac.at (PM); Helmut.Klocker@uki.at (HK)

  Affiliations Division of Experimental Urology, Department of Urology, Innsbruck Medical University, Innsbruck, Austria, Oncotyrol, Center for Personalized Cancer Medicine GmbH, Innsbruck, Austria

  ⨯